Category: Diseases & Conditions
Diseases & Conditions market research reports by DelveInsight
-
Alzheimer's Disease - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights In 2023, the 7MM reported approximately 15,840 thousand diagnosed prevalent cases of Alzheimer’s disease, reflecting a significant disease burden. This high prevalence underscores the need for innovative treatments to address the rising impact on healthcare systems and patient care. I ... Read More
-
Ewing Sarcoma - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights In 2023, the US accounted for the maximum share of the Ewing sarcoma Treatment Market in the 7MM, i.e., nearly 53%. A molecular-targeted therapy with minimal risk of late toxicities would be beneficial because most Ewing sarcoma Patients are under 20 years old. Although there is no st ... Read More
-
Heparin-induced Thrombocytopenia - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights The heparin-induced thrombocytopenia market size in the 7MM is estimated to be around ~USD 128 million, in 2023. Heparin-induced thrombocytopenia is characterized by a rapid decrease in platelet count occurring 5–14 days after the initiation of heparin therapy. It is primarily caused ... Read More
-
Postpartum Depression - Market Insights, Epidemiology, and Market Forecast - 2034
Key Highlights The Postpartum Depression Treatment Market Size in the 7MM was estimated to be USD 260 million in 2023. Among EU4 and the UK, the UK accounted for the highest Postpartum Depression Market Size of ~USD 25 Million in 2023. Among the seven major countries, the Postpartum Depression diagn ... Read More
-
B-cell Lymphoma- Pipeline Insight, 2025
DelveInsight’s, “B-cell Lymphoma- Pipeline Insight, 2025” report provides comprehensive insights about 295+ companies and 300+ pipeline drugs in B-cell Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutic ... Read More
-
Diabetic Nephropathy- Pipeline Insight, 2025
DelveInsight’s, “Diabetic Nephropathy- Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Diabetic Nephropathy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the the ... Read More
-
Huntington’s Disease - Pipeline Insight, 2025
DelveInsight’s, “Huntington’s Disease - Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Huntington’s Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the t ... Read More
-
Chronic Spinal Cord Injury- Pipeline Insight, 2025
DelveInsight’s, “Chronic Spinal Cord Injury- Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 5+ pipeline drugs in Chronic Spinal Cord Injury pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also cove ... Read More
-
Postpartum Depression - Pipeline Insight, 2025
DelveInsight’s, “Postpartum Depression - Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Postpartum Depression pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ... Read More
-
Metastatic Colorectal Cancer - Pipeline Insight, 2025
DelveInsight’s, “Metastatic Colorectal Cancer - Pipeline Insight, 2025” report provides comprehensive insights about 150+ companies and 180+ pipeline drugs in Metastatic Colorectal Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It ... Read More
-
Allergic Rhinitis - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights In 2023, the Allergic Rhinitis Market Size was highest in the US among the 7MM, accounting for approximately USD 3,600 million which is further expected to increase by 2034. In 2023, the prevalence of Allergic rhinitis was highest in Japan among the 7MM, accounting for approximately 6 ... Read More
-
Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2025
DelveInsight’s, “Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insight, 2025” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and non ... Read More
-
Ocular Hypertension - Pipeline Insight, 2025
DelveInsight’s, “Ocular Hypertension - Pipeline Insight, 2025” report provides comprehensive insights about 50+ companies and 75+ pipeline drugs in Ocular Hypertension pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ther ... Read More
-
Ebola Fever - Pipeline Insight, 2025
DelveInsight’s, “Ebola Fever - Pipeline Insight, 2025” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Ebola Fever pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessmen ... Read More
-
Advanced Melanoma - Pipeline Insight, 2025
DelveInsight’s, “Advanced Melanoma - Pipeline Insight, 2025” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Advanced Melanoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeu ... Read More
-
Multiple Myeloma - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights The total market size in the 7MM for multiple myeloma was estimated to be nearly USD 21,300 million in 2023, which is expected to show positive growth by 2034, owing to rise in incident cases, label expansion and penetration of current therapies in earlier lines, high adoption of newe ... Read More
-
Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025
DelveInsight’s, “Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025” report provides comprehensive insights about 2+ companies and 3+ pipeline drugs in Guillain-Barré Syndrome (GBS) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It al ... Read More
-
Postmenopausal Osteoporosis - Pipeline Insight, 2025
DelveInsight’s, “Postmenopausal Osteoporosis - Pipeline Insight, 2025” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Postmenopausal Osteoporosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also ... Read More
-
Refractory Metastatic Melanoma - Pipeline Insight, 2025
DelveInsight’s, “Refractory Metastatic Melanoma - Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Refractory Metastatic Melanoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It ... Read More
-
EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) - Pipeline Insight, 2024
EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) - Pipeline Insight, 2024 DelveInsight’s, “EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) - Pipeline Insight, 2024” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) pipeli ... Read More
-
Peanut Allergy - Pipeline Insight, 2024
Peanut Allergy - Pipeline Insight, 2024 DelveInsight’s, “Peanut Allergy - Pipeline Insight, 2024,” report provides comprehensive insights about 12+ companies and 15+ pipeline drugs in Peanut Allergy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage pr ... Read More
-
PD-1 and PD-L1 Inhibitors - Competitive landscape, 2024
PD-1 and PD-L1 Inhibitors - Competitive landscape, 2024 DelveInsight’s, “PD-1 and PD-L1 Inhibitors - Competitive landscape, 2024,” report provides comprehensive insights about 180+ companies and 200+ drugs in PD-1 and PD-L1 Inhibitors Competitive landscape. It covers the therapeutics assessment by ... Read More
-
Pancreatic Cancer - Competitive Landscape, 2024
Pancreatic Cancer - Competitive Landscape, 2024 DelveInsight’s, “Pancreatic Cancer - Competitive landscape, 2024,” report provides comprehensive insights about 180+ companies and 190+ drugs in Pancreatic Cancer Competitive landscape. It covers the therapeutics assessment by product type, stage, rou ... Read More
-
Immunohistochemistry (IHC) - Market Insights, Competitive Landscape, and Market Forecast- 2030
Immunohistochemistry (IHC) - Market Insights, Competitive Landscape, and Market Forecast- 2030 Immunohistochemistry (IHC) Market by Product Type (Instruments, Reagents & Kits, and Services), Application (Diagnostic, Research, and Forensic), End-User (Hospitals & Diagnostic Laboratories, Academic & R ... Read More
-
Ebola Virus- Competitive Landscape, 2024
Ebola Virus- Competitive Landscape, 2024 DelveInsight’s, “Ebola Virus- Competitive landscape, 2024,” report provides comprehensive insights about 18+ companies and 20+ drugs in Ebola Virus Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, a ... Read More
Research Assistance
